Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

Pharmaceutical Preparations CT, United States
Nasdaq: BIOD
Biodel, Inc. is a development stage biopharmaceutical company. It is focused on the development and commercialization of innovative treatments for diabetes. The company develops product candidates by applying its proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. It develops novel forms of insulin and other peptide hormones for use in treating diabetes and its complications, including hyperglycemia, hypoglycemia, cardiovascular complications and weight control. Biodel was founded by Solomon S. Steiner and Erik I. Steiner on December 3, 2003 and is headquartered in Danbury, CT.
Similar to: Skystar Bio-Pharmaceutical Co., Columbia Laboratories, Inc., Sanofi
Vancouver, BC, CA
Aben Resources (TSX.V: ABN) is a Canadian gold and silver exploration company with a focus on developing properties in the Yukon.… Learn more →

Paris, FR
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’… Learn more →

Livingston, NJ, US
Columbia Laboratories, Inc. develops, manufactures and sells pharmaceutical products. Its pharmaceutical products include CRINONE… Learn more →

Xi'an, SA, CN
Skystar Bio-Pharmaceutical Co. engages in the research, development, production, marketing and sale of veterinary healthcare and medical… Learn more →